PPRV antibodies in serum samples. The method eliminated the requirement for virus culture and monoclonal antibody preparation, reduced the biorisk posed by virus-dependent manipulations, and the performance of the resultant cELISA compared favorably with a commercially available cELISA kit. Copyright © 2012 S. Karger AG, Basel Peste des petits ruminants (PPR) is an acute, highly contagious and economically important viral disease with morbidity and mortality rates as high as 100 and 90%, respectively [1] . PPR, a contagion of goats and sheep, is characterized by severe pyrexia, oculonasal discharges, necrotizing and erosive stomatitis, enteritis and pneumonia. Initially epidemic in Ivory Coast and West Africa [2] , the disease later spread across sub-Saharan Africa, the Arabian Peninsula and Southwest Asia [3] . In July 2007, an outbreak of PPR in the southwestern Ngari region of Tibet resulted in heavy mortality among the goat population and huge economic losses to local farmers [4] .
The causative agent, peste des petits ruminants virus (PPRV), is an enveloped RNA virus belonging to the genus Morbillivirus of the family Paramyxoviridae that has a single-stranded, negative-sense RNA genome encoding eight proteins in the order 3 -N-P/C/V-M-F-H-L-5 . PPRV is most closely related antigenically to rinderpest virus (RPV) [5] , another member of the genus Morbillivirus , which can infect all artiodactyl species, with cattle and buffalo being the most susceptible [6] . Laboratory confirmation of PPRV infection is normally carried out using an enzyme-linked immunosorbent assay (ELISA) but diagnosis of PPR is often ambiguous in areas where the disease coexists with RPV. Various ELISA protocols, employing monoclonal antibody raised either against hemagglutinin protein [7, 8] or nucleoprotein [9] , have been developed. At present, two ELISA kits are available commercially [7, 9, 10] , both of which employ monoclonal antibodies developed using African lineages of PPRVs or their expressed antigens.
In the initial period of a PPRV epidemic, quarantine measures to isolate infected animals are essential to control the rapid spread of the disease. For this reason, effective diagnostic kits for antigen or antibody detection are required by countries and regions threatened by PPRV epidemics. In order to address this need, we set out to develop a competitive ELISA-based system (cELISA) for detecting serum antibody against PPRV in which the coating antigen was artificially synthesized PPRV nucleocapsid (N) protein and the competitive polyclonal serum was obtained by immunizing animals with synthetic peptides that included specific PPRV epitopes. Such peptides have been used to detect serum antibodies because they are cheaper to produce than the entire protein [11, 12] , exhibit good immunogenicity and can be employed to produce hyperimmune antiserum for ELISAs. Theoretically, the method should be capable of differentiating between PPR and rinderpest.
Recombinant N protein of Tibetan PPRV employed as capture antigen was prepared as described previously [13] . Four peptides of the N protein were synthesized by GL Biochem (Shanghai) Ltd and designated as follows: TPA (132-145) STEGPSSGGKKRIN, TPB (433-443) ATREGVKAAIP, TPC (467-473) LLPEIMP, and TPD (455-473) RPGRPRGETPGQLLLEIMP. Peptide sequences were selected according to Dechamma et al. [14] .
For the screening of peptides before immunizing rabbits, wells of ELISA plates (Maxisorp F96; Nunc, Kamstrup, Denmark) were coated with the synthetic peptides in carbonate-bicarbonate buffer overnight at 4° and blocked with 100 l of 5% skimmed milk powder in phosphate-buffered saline (PBS) for 2 h at 37°. After washing with PBS Tween 20, goat anti-PPRV and goat anti-RPV sera were added to duplicate wells and incubated for 1 h at 37°. After washing as before, rabbit anti-goat IgG (Immunology Consultants Laboratory, Newberg, Oreg., USA), diluted 1: 8,000 and conjugated with horseradish peroxidase (Santa Cruz Biotechnology, Santa Cruz, Calif., USA), was added followed by incubation for 1 h at 37°. Antigen-antibody reactions were detected using 3,3 ,5,5 -tetramethylbenzidine and measured spectrophotometrically at 450 nm.
Previously confirmed PPRV-negative serum samples (n = 488) were employed to determine the cutoff value of the epitope-based cELISA, and 1,039 serum samples were used to assess the validity of the epitope-based cELISA compared with a commercial cELISA kit (Cirad Bios, UPR15, TA A-15/G Campus International Baillarguet, Montpellier, France). A total of 770 recently collected serum samples of well-defined origin and history were evaluated using the newly established cELISA to determine the immunization state of animals raised in a PPRVinfected area of Tibet.
Peptide antiserum was obtained by intramuscular injection of female New Zealand white rabbits ( ϳ 1 kg body weight) at four multiple sites with 75 mg of TPD dissolved in 500 l of PBS mixed with an equal volume of Freund's complete adjuvant (Sigma-Aldrich, San Francisco, Calif., USA). Animals were given booster doses of the same antigen mixed with Freund's incomplete adjuvant (SigmaAldrich) 28, 40 and 60 days after the first injection. Hyperimmune serum (peptide antiserum) was dialyzed against 0.15 M PBS for 48 h at 4°, changing the buffer every 12 h, sterilized by filtration and stored at -20°.
Peptide antiserum titers were measured by indirect ELISA accomplished as follows: wells of ELISA plates were coated with recombinant N protein in carbonatebicarbonate buffer overnight at 4° and then blocked with 100 l of 5% skimmed milk powder in PBS for 2 h at 37°. After washing with PBS Tween 20, rabbit sera (0, 7, 18, 35, 55, 65 and 90 dpi) were added to duplicate wells and incubated for 1 h at 37°. After washing as before, goat antirabbit IgG diluted 1: 8,000 and conjugated with horseradish peroxidase (Abgent, San Diego, Calif., USA) was added, followed by incubation for 1 h at 37°. Antigen-antibody reactions were detected using 3,3 ,5,5 -tetramethyl benzidine and measured at 450 nm.
Conditions used for the competitive ELISA were based on the method described for detecting RPV-specific antibody [15] . Microtiter ELISA plates were coated with 100 l recombinant N protein (320 ng/ml) for 1 h at 37° with constant agitation. After adsorption of the antigen, test sera at a final dilution of 1: 20 were incubated simultaneously with rabbit hyperimmune serum (final dilution 1: 1,000) in blocking buffer (supplemented with 0.5% lamb serum). Wells without test and hyperimmune serum served as the conjugate control (100% competition), and wells without test serum served as the hyperimmune serum control (0% competition). Serum controls included wells with a strong positive, a weak positive or a negative serum to ensure that similar levels of inhibition were obtained between tests. Absorbance values were converted to percentage inhibition (PI) values using the following formula:
where 'A 450 test' denotes absorbance values of wells containing test sera and 'A 450 0% control' denotes absorbance values of wells containing hyperimmune serum without test serum. The antigen concentration that gave 75% of the A 450 plateau in the indirect ELISA was employed as the optimum coating concentration, and the optimum antibody concentration was determined using the checkerboard titration test [16, 17] . To determine the optimum antigen/ antibody binding time, the standard deviation (SD) values of three tests (in which the reactants were allowed to bind for 15, 30 and 60 min, respectively) using eight different serum samples were compared (each measurement was carried out 4 times), and the value with the smallest SD was adopted as optimal.
The mean PI value obtained for 488 negative serum samples plus twice the SD value was adopted as the cutoff value for the cELISA. Reproducibility of the assay was determined using 20 serum samples. For each sample, the coefficient of variation (CV) was calculated between plates using four different plates on different occasions (interassay variation) and four replicates within the same plate (intra-assay variation).
Each of the four peptides bound to PPRV antiserum, with the strongest affinity observed with TPD, whereas only relatively very weak binding was recorded between the epitopes and RPV antiserum ( fig. 1 ) . The difference in the binding affinity of TPD for PPRV and RPV antisera was sufficiently significant (p ! 0.01) to suggest employing the epitope for the differential diagnosis of PPRV and RPV infections. Indirect ELISA revealed that the level of reactivity between hyperimmune sera and N protein increased following booster immunizations ( fig. 2 ).
An A 450 value of 1.074, 75% of the maximum A 450 value of 1.40 achieved with undiluted antigen, was obtained with 320 ng/ml of the coating antigen. Selecting this con- centration as optimal, the maximum difference between the PI values of positive and negative samples was recorded using 1: 1,000 and 1: 5 dilutions of rabbit hyperimmune serum and test sera, respectively. SD values for 32 positive serum samples were 12.75, 9.38, and 7.44 when reaction times of 15, 30 and 60 min were employed, respectively, and the latter was selected for future experiments accordingly.
Using the mean PI value (18.07) obtained for 488 negative serum samples (198 goat and 290 sheep) plus twice the SD (8.39), the cutoff value for the cELISA was calculated to be 35. Interassay CVs ranged from 2.1 to 5.9% (average 2.89%), and the intra-assay CV ranged from 1.5 to 4.7% (average 2.32%), based on 20 selected serum samples.
Totally, 333 and 706 serum samples were judged to be anti-PPRV positive and negative, respectively, by the commercial cELISA kit. Of the 333 positive samples, 304 were also judged to be positive by the epitope-based cELI-SA, corresponding to a relative specificity of 91.29%. Of the 706 negative samples, 679 were similarly assessed by the epitope-based cELISA, corresponding to a relative sensitivity of 96.18%.
PPRV antibody titers in serum from naturally infected animals were markedly higher compared with vaccinated animals. PI values of 36.7 (scored positive) were recorded in 20-fold dilutions of serum from naturally infected animals, whereas 10-fold dilutions of 10 (from 12) serum samples taken from vaccinated animals gave PI values below the 35 cutoff level (scored negative).
Of 770 serum samples taken from the Ali region of Tibet (which consists of Rutog, Gegyai, Gerze and Zanda counties), 91 tested positive using the epitope-based cELISA ( table 1 ) . A relatively higher proportion of positives were recorded among samples from Rutog, Gegyai and Gerze counties compared with Zanda ( table 1 ) . PI values of the Tibetan samples fluctuated around 30 with a maximum of 42.
In this study, we sought to develop a cELISA for detecting PPRV infections by substituting monoclonal antibody with hyperimmune serum obtained by immunizing animals with synthetic epitope peptides derived from the PPRV N protein. Another unique feature of this cELI-SA was the Tibetan PPRV N protein (expressed from a chemically synthesized gene) employed as the coating antigen. We adopted this approach in order to avoid the hazards associated with handling PPRV, a list A animal pathogen that requires a BSL-3 facility.
Among the structural proteins of morbilliviruses, the N protein is the most immunogenic and has a highly conserved structure [18] . Dechamma et al. [14] identified PPRV-specific antigen epitopes at the 132-145, 433-443 and 454-472 segments of the N protein, which suggested these segments might be used for the differential diagnosis of PPRV and RPV infections. We have now confirmed that four synthesized epitopes, TPA, TPB, TPC and TPD, induced hyperimmune sera, and that TPD exhibited the highest affinity for PPRV antibody. We have also demonstrated that the hyperimmune serum obtained by immunizing animals with TPD together with Freund's complete adjuvant is suitable for use in a competitive ELISA.
The epitope-based cELISA had a specificity of 96.18% and a sensitivity of 91.29% compared to a commercial cELISA kit (Cirad Bios), which is an authorized product and exhibits good agreement with a VNT [10] . The average CVs were less than 3% in both intra-and interassays using the epitope-based cELISA, indicating a high degree of reproducibility.
Most of the PPRV-positive serum samples examined in this study were collected from the Ali region of Tibet and, with PI values ! 42, were assessed as weak positive, implying that the animals concerned were only weakly immunized. Since the antigen used to prepare the competitive antiserum had only a low affinity for RPV-positive antisera, the method should, theoretically, be able to distinguish between antibodies to PPRV and RPV. 
